The radiopharmaceutical consists of a radioactive molecule – in this case terbium-161 linked to a ligand. This ligand recognises proteins on the tumour cell, allowing highly targeted cancer treatment.

If you can get rid of circulating tumor cells and tumor cell clusters that detach from a tumor, spreading the disease in the body, cancer is less likely to return. This is the hope behind a ...